SoFi Technologies Inc. (SOFI) received a bullish endorsement from William Blair on Tuesday, following its second-quarter (Q2) ...

Sarepta Therapeutics shares surged more than 30% before the bell on Tuesday, as analysts said the resumption of U.S. shipments for its muscular gene therapy partially removes financial headwinds and ...

William Blair cheers Tesla-Samsung chip deal but keeps TSLA at Hold, citing auto margin woes and valuation concerns.

Jed Dorsheimer, William Blair analyst, joins 'The Exchange' to discuss Tesla's chip deal with Samsung and what it means for the stock.

In its own communique issued shortly after the FDA’s, Sarepta elaborated on the situation and confirmed a Roche statement to ...

FDA probes Elevidys after an 8-year-old's death in Brazil; Sarepta and Roche say the death was unrelated to gene therapy ...

In addition, The Allstate Corporation (NYSE:ALL) is taking advantage of a far better auto loss environment and employing ...

The company didn’t share specific data for the molecule, gefurulimab, but said it hit all endpoints in the Phase III PREVAIL ...

Tesla's growing pains might have hit the company where it hurts post-earnings, but there is potential if the company can ...

This AI giant dominates the market, and despite its explosive growth, the stock might be cheaper than you think.

Local news on this date July 26, 1950 Company D, 6th infantry battalion, U.S. Marine Corps Reserves, Capt. William C. Bell commanding, became the third Blair County military reserve unit to be called ...

William Blair analysts lowered their rating on Ameriprise stock to Market Perform from Outperform Friday following the financial services firm’s second-quarter report.